Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  HIV Infection

  Free Subscription


04.02.2019

15 AIDS
3 AIDS Res Hum Retroviruses
1 Am J Epidemiol
1 Antivir Ther
1 BMC Pediatr
1 Cell
3 Clin Infect Dis
6 HIV Med
1 J Acquir Immune Defic Syndr
2 J Clin Invest
1 J Infect Dis
1 J Med Virol
4 J Virol
3 Lancet Glob Health
4 Lancet HIV
2 Lancet Public Health
1 MMWR Morb Mortal Wkly Rep
1 Nature
1 Pediatrics
1 PLoS Comput Biol
17 PLoS One


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    AIDS

  1. KOENIG LJ, O'Leary A
    Improving health outcomes for women with HIV: the potential impact of addressing internalized stigma and depression.
    AIDS. 2019;33:577-579.
    PubMed     Text format    

  2. GUERVENO C, Raymond S, Metsu D, Gandia P, et al
    HIV-1 escape in the central nervous system on elvitegravir-based antiretroviral therapy.
    AIDS. 2019;33:593-594.
    PubMed     Text format    

  3. ZAUNDERS J
    Intersection of immune checkpoints and CD8+ T cell noncytolytic suppression of HIV-1 infection: putting on the brakes versus the nuclear option.
    AIDS. 2019;33:581-583.
    PubMed     Text format    

  4. TURAN B, Rice WS, Crockett KB, Johnson M, et al
    Longitudinal association between internalized HIV stigma and antiretroviral therapy adherence for women living with HIV: the mediating role of depression.
    AIDS. 2019;33:571-576.
    PubMed     Text format     Abstract available

  5. TOMITA A, Vandormael A, Barnighausen T, Phillips A, et al
    Sociobehavioral and community predictors of unsuppressed HIV viral load: multilevel results from a hyperendemic rural South African population.
    AIDS. 2019;33:559-569.
    PubMed     Text format     Abstract available

  6. CONNOR RI, Zain-Ul-Abideen M, Magohe AK, Brickley EB, et al
    Sialic acid levels in breast milk from HIV-positive Tanzanian women and impact of maternal diet.
    AIDS. 2019;33:509-514.
    PubMed     Text format     Abstract available

  7. MACHIELS JD, Braam EE, van Bentum P, van Vugt M, et al
    Vaccination with Fendrix of prior nonresponding patients with HIV has a high success rate.
    AIDS. 2019;33:503-507.
    PubMed     Text format     Abstract available

  8. BELLAGAMBA R, Giancola ML, Tommasi C, Piselli P, et al
    Randomized clinical trial on efficacy of fixed-dose efavirenz/tenofovir/emtricitabine on alternate days versus continuous treatment.
    AIDS. 2019;33:493-502.
    PubMed     Text format     Abstract available

  9. PEREZ-VALERO I, Ellis R, Heaton R, Deutsch R, et al
    Cerebrospinal fluid viral escape in aviremic HIV-infected patients receiving antiretroviral therapy: prevalence, risk factors and neurocognitive effects.
    AIDS. 2019;33:475-481.
    PubMed     Text format     Abstract available

  10. CHRISTIAN B, Fabian E, Macha I, Mpangala S, et al
    Hepatitis B virus coinfection is associated with high early mortality in HIV-infected Tanzanians on antiretroviral therapy.
    AIDS. 2019;33:465-473.
    PubMed     Text format     Abstract available

  11. SHARMA A, Shi Q, Hoover DR, Tien PC, et al
    Frailty predicts fractures among women with and at-risk for HIV.
    AIDS. 2019;33:455-463.
    PubMed     Text format     Abstract available

  12. PANNUS P, Adams P, Willems E, Heyndrickx L, et al
    In-vitro viral suppressive capacity correlates with immune checkpoint marker expression on peripheral CD8+ T cells in treated HIV-positive patients.
    AIDS. 2019;33:387-398.
    PubMed     Text format     Abstract available

  13. NEL JS, Gay CL, Lachiewicz AM
    Further complexities in interpreting the serologic responses in HIV-negative recipients of HIV-positive organs.
    AIDS. 2019;33:595-596.
    PubMed     Text format    

  14. LAKE JE, Clark JL
    Optimizing HIV prevention and care for transgender adults.
    AIDS. 2019;33:363-375.
    PubMed     Text format     Abstract available

  15. GIRARD A, Rallon N, Benito JM, Jospin F, et al
    A high mucosal blocking score is associated with HIV protection.
    AIDS. 2019;33:411-423.
    PubMed     Text format     Abstract available


    AIDS Res Hum Retroviruses

  16. SUN L, Jia L, Liu Y, Han J, et al
    Multiple HIV-1 subtypes were found circulating in Shijingshan District of Beijing, China.
    AIDS Res Hum Retroviruses. 2019 Jan 25. doi: 10.1089/AID.2018.0263.
    PubMed     Text format     Abstract available

  17. AMBIKE S, Thakar M, Patil A, Gangakhedkar RR, et al
    Partial <i>pol</i> sequences from drug naive HIV-2 infected individuals from Maharashtra, India.
    AIDS Res Hum Retroviruses. 2019 Jan 25. doi: 10.1089/AID.2018.0282.
    PubMed     Text format     Abstract available

  18. CHAI PR, Pereira L, Jambaulikar G, Carrico AW, et al
    Bioequivalence of Tenofovir Component of Tenofovir/Rilpivirine/Emtricitabine in Digital Pills.
    AIDS Res Hum Retroviruses. 2019 Jan 29. doi: 10.1089/AID.2018.0073.
    PubMed     Text format     Abstract available


    Am J Epidemiol


  19. RE: "DESIGN STRATEGY OF THE SABES STUDY: DIAGNOSIS AND TREATMENT OF EARLY HIV INFECTION AMONG MEN WHO HAVE SEX WITH MEN AND TRANSGENDER WOMEN IN LIMA, PERU, 2013-2017".
    Am J Epidemiol. 2018;187:1828.
    PubMed     Text format    


    Antivir Ther

  20. HALLORAN MO, Boyle C, Kehoe B, Bagkeris E, et al
    Polypharmacy and drug-drug interactions in older and younger people living with HIV: the POPPY study.
    Antivir Ther. 2019 Jan 31. doi: 10.3851/IMP3293.
    PubMed     Text format     Abstract available


    BMC Pediatr

  21. HAILE GS, Berha AB
    Predictors of treatment failure, time to switch and reasons for switching to second line antiretroviral therapy in HIV infected children receiving first line anti-retroviral therapy at a Tertiary Care Hospital in Ethiopia.
    BMC Pediatr. 2019;19:37.
    PubMed     Text format     Abstract available


    Cell

  22. WANG X, Xuan Y, Han Y, Ding X, et al
    Regulation of HIV-1 Gag-Pol Expression by Shiftless, an Inhibitor of Programmed -1 Ribosomal Frameshifting.
    Cell. 2019;176:625-635.
    PubMed     Text format     Abstract available


    Clin Infect Dis

  23. BORAND L, de Lauzanne A, Nguyen NL, Cheng S, et al
    Isolation of Nontuberculous Mycobacteria in Southeast Asian and African Human Immunodeficiency Virus-infected Children With Suspected Tuberculosis.
    Clin Infect Dis. 2019 Jan 28. pii: 5303788. doi: 10.1093.
    PubMed     Text format     Abstract available

  24. ONG JJ, Magooa MP, Chikandiwa A, Kelly H, et al
    Prevalence and antimicrobial resistance of Mycoplasma genitalium infection among women living with HIV in South Africa: a prospective cohort study.
    Clin Infect Dis. 2019 Jan 29. pii: 5303854. doi: 10.1093.
    PubMed     Text format     Abstract available

  25. CALABRESE SK, Krakower DS, Willie TC, Kershaw TS, et al
    US Guideline Criteria for HIV Pre-Exposure Prophylaxis: Clinical Considerations and Caveats.
    Clin Infect Dis. 2019 Jan 28. pii: 5303779. doi: 10.1093.
    PubMed     Text format     Abstract available


    HIV Med

  26. IRELAND G, Simmons R, Balogun K, Kirwan P, et al
    HIV coinfection among persons diagnosed with hepatitis B in England in 2008-2014.
    HIV Med. 2019 Jan 28. doi: 10.1111/hiv.12707.
    PubMed     Text format     Abstract available

  27. JOHNSON SM, Standing JF, Klein N, Irwin AD, et al
    A case for reduced frequency of CD4 count monitoring for children on combination antiretroviral therapy with consistently undetectable HIV viral load.
    HIV Med. 2019 Jan 28. doi: 10.1111/hiv.12706.
    PubMed     Text format    

  28. GRABAR S, Hleyhel M, Belot A, Bouvier AM, et al
    Invasive cervical cancer in HIV-infected women: risk and survival relative to those of the general population in France. Results from the French Hospital Database on HIV (FHDH)-Agence Nationale de Recherches sur le SIDA et les Hepatites Virales (ANRS)
    HIV Med. 2019 Jan 28. doi: 10.1111/hiv.12703.
    PubMed     Text format     Abstract available

  29. MALIN JJ, Boesecke C, Schwarze-Zander C, Wasmuth JC, et al
    Liver stiffness regression after successful Hepatitis C treatment is independent of HIV coinfection.
    HIV Med. 2019 Jan 27. doi: 10.1111/hiv.12705.
    PubMed     Text format     Abstract available

  30. LLIBRE JM, Montoliu A, Miro JM, Domingo P, et al
    Discontinuation of dolutegravir, elvitegravir/cobicistat and raltegravir because of toxicity in a prospective cohort.
    HIV Med. 2019 Jan 27. doi: 10.1111/hiv.12710.
    PubMed     Text format     Abstract available

  31. MATIGNON M, Lelievre JD, Lahiani A, Abbassi K, et al
    Low incidence of acute rejection within 6 months of kidney transplantation in HIV-infected recipients treated with raltegravir: the Agence Nationale de Recherche sur le Sida et les Hepatites Virales (ANRS) 153 TREVE trial.
    HIV Med. 2019 Jan 27. doi: 10.1111/hiv.12700.
    PubMed     Text format     Abstract available


    J Acquir Immune Defic Syndr

  32. SIBIUDE J, Warszawski J, Tubiana R, Chenadec JL, et al
    Liver Enzyme Elevation in Pregnant Women Receiving Antiretroviral Therapy in the ANRS-French Perinatal Cohort.
    J Acquir Immune Defic Syndr. 2019 Jan 17. doi: 10.1097/QAI.0000000000001963.
    PubMed     Text format     Abstract available


    J Clin Invest

  33. STONE NR, Rhodes J, Fisher MC, Mfinanga S, et al
    Dynamic ploidy changes drive fluconazole resistance in human cryptococcal meningitis.
    J Clin Invest. 2019 Jan 28. pii: 124516. doi: 10.1172/JCI124516.
    PubMed     Text format     Abstract available

  34. EINKAUF KB, Lee GQ, Gao C, Sharaf R, et al
    Intact HIV-1 proviruses accumulate at distinct chromosomal positions during prolonged antiretroviral therapy.
    J Clin Invest. 2019 Jan 28. pii: 124291. doi: 10.1172/JCI124291.
    PubMed     Text format     Abstract available


    J Infect Dis

  35. FREEMAN ML, Panigrahi S, Chen B, Juchnowski S, et al
    CD8+ T Cell-Derived Tumor Necrosis Factor Can Induce Tissue Factor Expression on Monocytes.
    J Infect Dis. 2019 Jan 29. pii: 5304106. doi: 10.1093.
    PubMed     Text format     Abstract available


    J Med Virol

  36. GOPALAN BP, D'Souza RR, Rajnala N, Arumugam K, et al
    Viral evolution in the cell-associated HIV-1 DNA during early ART can lead to drug-resistance and virological failure in children.
    J Med Virol. 2019 Jan 29. doi: 10.1002/jmv.25413.
    PubMed     Text format     Abstract available


    J Virol

  37. MAYBERRY CL, Soucy AN, Lajoie CR, DuShane JK, et al
    JC Polyomavirus Entry by Clathrin-Mediated Endocytosis is Driven by beta-arrestin.
    J Virol. 2019 Jan 30. pii: JVI.01948-18. doi: 10.1128/JVI.01948.
    PubMed     Text format     Abstract available

  38. TAY MZ, Kunz EL, Deal A, Zhang L, et al
    Rare Detection of Antiviral Functions of Polyclonal IgA Isolated from Plasma and Breast Milk Compartments in HIV-1 Chronically Infected Women.
    J Virol. 2019 Jan 30. pii: JVI.02084-18. doi: 10.1128/JVI.02084.
    PubMed     Text format     Abstract available

  39. VIBHOLM LK, Lorenzi JCC, Pai JA, Cohen YZ, et al
    Characterization of intact proviruses in blood and lymph node from HIV-infected individuals undergoing analytical treatment interruption.
    J Virol. 2019 Jan 30. pii: JVI.01920-18. doi: 10.1128/JVI.01920.
    PubMed     Text format     Abstract available

  40. POHLMEYER CW, Gonzalez VD, Irrinki A, Ramirez RN, et al
    Identification of NK cell subpopulations that differentiate HIV-infected subject cohorts with diverse level of virus control.
    J Virol. 2019 Jan 30. pii: JVI.01790-18. doi: 10.1128/JVI.01790.
    PubMed     Text format     Abstract available


    Lancet Glob Health

  41. REDDY KP, Gupta-Wright A, Fielding KL, Costantini S, et al
    Cost-effectiveness of urine-based tuberculosis screening in hospitalised patients with HIV in Africa: a microsimulation modelling study.
    Lancet Glob Health. 2019;7:e200-e208.
    PubMed     Text format     Abstract available

  42. ZWERLING A
    Costs of tuberculosis screening among inpatients with HIV.
    Lancet Glob Health. 2019;7:e163-e164.
    PubMed     Text format    

  43. DI TANNA GL, Raza Khaki A, Theron G, McCarthy K, et al
    Effect of Xpert MTB/RIF on clinical outcomes in routine care settings: individual patient data meta-analysis.
    Lancet Glob Health. 2019;7:e191-e199.
    PubMed     Text format     Abstract available


    Lancet HIV


  44. Correction to Lancet HIV 2018; 5: e553-59.
    Lancet HIV. 2019 Jan 25. pii: S2352-3018(19)30009.
    PubMed     Text format    

  45. THE LANCET HIV
    For the greatest impact, end caps on PrEP access now.
    Lancet HIV. 2019 Jan 24. pii: S2352-3018(19)30006.
    PubMed     Text format    

  46. RASMUSSEN LD, Obel N
    How do we preserve health among adults living with HIV?
    Lancet HIV. 2019 Jan 22. pii: S2352-3018(18)30336.
    PubMed     Text format    

  47. ALTHOFF KN, Gebo KA, Moore RD, Boyd CM, et al
    Contributions of traditional and HIV-related risk factors on non-AIDS-defining cancer, myocardial infarction, and end-stage liver and renal diseases in adults with HIV in the USA and Canada: a collaboration of cohort studies.
    Lancet HIV. 2019 Jan 22. pii: S2352-3018(18)30295.
    PubMed     Text format     Abstract available


    Lancet Public Health

  48. BORQUEZ A, Guanira JV, Revill P, Caballero P, et al
    The impact and cost-effectiveness of combined HIV prevention scenarios among transgender women sex-workers in Lima, Peru: a mathematical modelling study.
    Lancet Public Health. 2019 Jan 22. pii: S2468-2667(18)30236.
    PubMed     Text format     Abstract available

  49. PANOPOULOU G, Gonzalez-Pier E
    Challenges in HIV infection control in transgender women sex workers.
    Lancet Public Health. 2019 Jan 22. pii: S2468-2667(18)30259.
    PubMed     Text format    


    MMWR Morb Mortal Wkly Rep

  50. RAO S, Song W, Mulatu MS, Rorie M, et al
    HIV Partner Service Delivery Among Blacks or African Americans - United States, 2016.
    MMWR Morb Mortal Wkly Rep. 2019;68:81-86.
    PubMed     Text format     Abstract available


    Nature

  51. BRUNER KM, Wang Z, Simonetti FR, Bender AM, et al
    A quantitative approach for measuring the reservoir of latent HIV-1 proviruses.
    Nature. 2019 Jan 30. pii: 10.1038/s41586-019-0898.
    PubMed     Text format     Abstract available


    Pediatrics

  52. LANGFITT JT, McDermott MP, Brim R, Mboma S, et al
    Neurodevelopmental Impairments 1 Year After Cerebral Malaria.
    Pediatrics. 2019 Jan 29. pii: peds.2018-1026. doi: 10.1542/peds.2018-1026.
    PubMed     Text format     Abstract available


    PLoS Comput Biol

  53. DUWAL S, Dickinson L, Khoo S, von Kleist M, et al
    Mechanistic framework predicts drug-class specific utility of antiretrovirals for HIV prophylaxis.
    PLoS Comput Biol. 2019;15:e1006740.
    PubMed     Text format     Abstract available


    PLoS One

  54. SHILI-MASMOUDI S, Sogni P, de Ledinghen V, Esterle L, et al
    Increased liver stiffness is associated with mortality in HIV/HCV coinfected subjects: The French nationwide ANRS CO13 HEPAVIH cohort study.
    PLoS One. 2019;14:e0211286.
    PubMed     Text format     Abstract available

  55. DESSILLY G, Goeminne L, Vandenbroucke AT, Dufrasne FE, et al
    Correction: First evaluation of the Next-Generation Sequencing platform for the detection of HIV-1 drug resistance mutations in Belgium.
    PLoS One. 2019;14:e0211587.
    PubMed     Text format     Abstract available

  56. FEYISSA GT, Lockwood C, Woldie M, Munn Z, et al
    Reducing HIV-related stigma and discrimination in healthcare settings: A systematic review of quantitative evidence.
    PLoS One. 2019;14:e0211298.
    PubMed     Text format     Abstract available

  57. BUI JK, Cyktor JC, Fyne E, Campellone S, et al
    Blockade of the PD-1 axis alone is not sufficient to activate HIV-1 virion production from CD4+ T cells of individuals on suppressive ART.
    PLoS One. 2019;14:e0211112.
    PubMed     Text format     Abstract available

  58. MODAI S, Farberov L, Herzig E, Isakov O, et al
    HIV-1 infection increases microRNAs that inhibit Dicer1, HRB and HIV-EP2, thereby reducing viral replication.
    PLoS One. 2019;14:e0211111.
    PubMed     Text format     Abstract available

  59. BELETE W, Deressa T, Feleke A, Menna T, et al
    Evaluation of diagnostic performance of non-invasive HIV self-testing kit using oral fluid in Addis Ababa, Ethiopia: A facility-based cross-sectional study.
    PLoS One. 2019;14:e0210866.
    PubMed     Text format     Abstract available

  60. CHETTY-MAKKAN CM, Grund JM, Munyai R, Gadla V, et al
    "To speak or not to speak": A qualitative analysis on the attitude and willingness of women to start conversations about voluntary medical male circumcision with their partners in a peri-urban area, South Africa.
    PLoS One. 2019;14:e0210480.
    PubMed     Text format     Abstract available

  61. OMANA-ZAPATA I, Mutschmann C, Schmitz J, Gibson S, et al
    Accurate and reproducible enumeration of T-, B-, and NK lymphocytes using the BD FACSLyric 10-color system: A multisite clinical evaluation.
    PLoS One. 2019;14:e0211207.
    PubMed     Text format     Abstract available

  62. BERNARDINO JI, Mocroft A, Wallet C, de Wit S, et al
    Body composition and adipokines changes after initial treatment with darunavir-ritonavir plus either raltegravir or tenofovir disoproxil fumarate-emtricitabine: A substudy of the NEAT001/ANRS143 randomised trial.
    PLoS One. 2019;14:e0209911.
    PubMed     Text format     Abstract available

  63. ADEM KS, Janakiraman B, Gebremeskel BF, Chala MB, et al
    Epidemiology and factors associated with peripheral neuropathy among HIV infected patients in Gondar, Ethiopia: A cross-sectional study.
    PLoS One. 2019;14:e0211354.
    PubMed     Text format     Abstract available

  64. KITONSA J, Mayanja Y, Aling E, Kiwanuka J, et al
    Factors affecting mortality among HIV positive patients two years after completing recommended therapy for Cryptococcal meningitis in Uganda.
    PLoS One. 2019;14:e0210287.
    PubMed     Text format     Abstract available

  65. GBADAMOSI SO, Itanyi IU, Menson WNA, Olawepo JO, et al
    Targeted HIV testing for male partners of HIV-positive pregnant women in a high prevalence setting in Nigeria.
    PLoS One. 2019;14:e0211022.
    PubMed     Text format     Abstract available

  66. ROCKSTROH JK, Asmuth D, Pantaleo G, Clotet B, et al
    Re-boost immunizations with the peptide-based therapeutic HIV vaccine, Vacc-4x, restores geometric mean viral load set-point during treatment interruption.
    PLoS One. 2019;14:e0210965.
    PubMed     Text format     Abstract available

  67. SMITH LM, Hein NA, Bagenda D
    Cash transfers and HIV/HSV-2 prevalence: A replication of a cluster randomized trial in Malawi.
    PLoS One. 2019;14:e0210405.
    PubMed     Text format     Abstract available

  68. NGUYEN KA, Peer N, de Villiers A, Mukasa B, et al
    Glycated haemoglobin threshold for dysglycaemia screening, and application to metabolic syndrome diagnosis in HIV-infected Africans.
    PLoS One. 2019;14:e0211483.
    PubMed     Text format     Abstract available

  69. SCHMITZ K, Basera TJ, Egbujie B, Mistri P, et al
    Impact of lay health worker programmes on the health outcomes of mother-child pairs of HIV exposed children in Africa: A scoping review.
    PLoS One. 2019;14:e0211439.
    PubMed     Text format     Abstract available

  70. HIPPNER P, Sumner T, Houben RM, Cardenas V, et al
    Application of provincial data in mathematical modelling to inform sub-national tuberculosis program decision-making in South Africa.
    PLoS One. 2019;14:e0209320.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO HIV Infection is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: